Arterra Bioscience S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 5.3 million compared to EUR 4.61 million a year ago. Net income was EUR 1.41 million compared to EUR 1.11 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 EUR | +2.67% | +6.08% | +15.66% |
Apr. 24 | ITALY GROWTH WINNERS & LOSERS: Askoll EVA rallying; Alfonsino trailing. | AN |
Apr. 02 | Arterra Bioscience with profit down; board confirms dividend | AN |
1st Jan change | Capi. | |
---|---|---|
+15.66% | 13.65M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABS Stock
- News Arterra Bioscience S.p.A.
- Arterra Bioscience S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022